|
|
5820 Nancy Ridge Drive
San Diego, CA 92121 USA
phone:(858) 860-2500
fax:(858) 860-2600
|
|
| Symbol |
EPMN |
| Exchange |
|
| Founded |
0 |
| Employees |
52 |
|
|
| www.epimmune.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Therapeutic vaccines to manage infectious diseases and cancer. |
|
| Management |
| Jakob Schmidt (Danish), Chief Executive Officer; Iben Dalum (Danish), Senior Vice President, R&D Laboratories and Chief Scientific Officer; Peter Nordkild (Danish), Chief Commercial Officer; Dana R. Leach (American), Senior Vice President, Business Development and Chief Operating Officer, DVM PhD; Torsten Skov (Danish), Senior Vice President of Drug Development; Marc Hertz (American), Chief Executive Officer of Pharmexa's subsidiary Pharmexa-Epimmune |
| |
|
|
|
|
|
|
|
| Keywords |
| infectious diseases, cancer, InfectiousDisease |
|
|
|
| Description |
|
Epimmune Inc. is developing therapeutic vaccines that use multiple epitopes, or protein fragments, to specifically activate the body's immune system for the more effective management of infectious diseases and cancer. |
|
| Products / Services |
The Company's vaccine candidate is designed to induce a sufficiently potent immune response so that the patient's immune system can control the virus, allowing the patient to suspend or stop taking antiretroviral drugs that have serious side effects and can induce drug resistance when taken over time.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members
